GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (NAS:EVO) » Definitions » Shiller PE Ratio

Evotec SE (Evotec SE) Shiller PE Ratio : 51.00 (As of Jun. 17, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Evotec SE Shiller PE Ratio?

As of today (2024-06-17), Evotec SE's current share price is $4.08. Evotec SE's E10 for the quarter that ended in Mar. 2024 was $0.08. Evotec SE's Shiller PE Ratio for today is 51.00.

The historical rank and industry rank for Evotec SE's Shiller PE Ratio or its related term are showing as below:

EVO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 49.38   Med: 154.45   Max: 592.25
Current: 51

During the past years, Evotec SE's highest Shiller PE Ratio was 592.25. The lowest was 49.38. And the median was 154.45.

EVO's Shiller PE Ratio is ranked worse than
86.33% of 534 companies
in the Drug Manufacturers industry
Industry Median: 24.31 vs EVO: 51.00

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Evotec SE's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.065. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.08 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Evotec SE Shiller PE Ratio Historical Data

The historical data trend for Evotec SE's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Shiller PE Ratio Chart

Evotec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 191.86 - 167.00 90.59 139.74

Evotec SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.30 127.86 134.74 139.74 99.52

Competitive Comparison of Evotec SE's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evotec SE's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Evotec SE's Shiller PE Ratio falls into.



Evotec SE Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Evotec SE's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=4.08/0.08
=51.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evotec SE's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Evotec SE's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.065/125.0381*125.0381
=-0.065

Current CPI (Mar. 2024) = 125.0381.

Evotec SE Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.002 99.543 -0.003
201409 -0.019 99.823 -0.024
201412 0.006 99.543 0.008
201503 -0.005 99.717 -0.006
201506 0.062 100.417 0.077
201509 -0.011 100.417 -0.014
201512 0.022 99.717 0.028
201603 -0.006 100.017 -0.008
201606 0.017 100.717 0.021
201609 0.039 101.017 0.048
201612 0.058 101.217 0.072
201703 0.027 101.417 0.033
201706 0.011 102.117 0.013
201709 0.012 102.717 0.015
201712 0.041 102.617 0.050
201803 0.012 102.917 0.015
201806 0.058 104.017 0.070
201809 0.134 104.718 0.160
201812 0.119 104.217 0.143
201903 0.051 104.217 0.061
201906 -0.011 105.718 -0.013
201909 0.072 106.018 0.085
201912 0.028 105.818 0.033
202003 0.061 105.718 0.072
202006 -0.039 106.618 -0.046
202009 -0.006 105.818 -0.007
202012 0.000 105.518 0.000
202103 0.190 107.518 0.221
202106 0.223 108.486 0.257
202109 0.482 109.435 0.551
202112 -0.113 110.384 -0.128
202203 -0.226 113.968 -0.248
202206 -0.085 115.760 -0.092
202209 -0.134 118.818 -0.141
202212 -0.079 119.345 -0.083
202303 -0.043 122.402 -0.044
202306 -0.043 123.140 -0.044
202309 -0.117 124.195 -0.118
202312 -0.049 123.773 -0.050
202403 -0.065 125.038 -0.065

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Evotec SE  (NAS:EVO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Evotec SE Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Evotec SE's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Evotec SE (Evotec SE) Business Description

Address
Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.